A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
about
Characterization of potent fusion inhibitors of influenza virusHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Singlet oxygen effects on lipid membranes: implications for the mechanism of action of broad-spectrum viral fusion inhibitors.Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors.Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagementEffects of singlet oxygen generated by a broad-spectrum viral fusion inhibitor on membrane nanoarchitectureA molecular tweezer antagonizes seminal amyloids and HIV infection.Broad-spectrum antivirals against viral fusion.The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus.The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses.Lipids in innate antiviral defense.Singlet oxygen generation by cyclometalated complexes and applications.Broad-spectrum antiviral agents.Development of Small-Molecule Antivirals for Ebola.Nanomedicine for Infectious Disease Applications: Innovation towards Broad-Spectrum Treatment of Viral Infections.Antiviral Lipopeptide-Cell Membrane Interaction Is Influenced by PEG Linker Length.Inhibition of an Aquatic Rhabdovirus Demonstrates Promise of a Broad-Spectrum Antiviral for Use in Aquaculture.Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.Antiviral Effects of Black Raspberry (Rubus coreanus) Seed and Its Gallic Acid against Influenza Virus InfectionVisually impaired researchers get their hands on quantum chemistry: application to a computational study on the isomerization of a sterol.Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope.Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure
P2860
Q28544971-635C2257-76D4-48D7-8415-01B2FD37AA38Q30386551-A2287DF5-A3A4-4C73-A9F0-5FCD4483A3A8Q33439713-F7FF55C9-C0C6-424F-9400-BC6DF98FE855Q34039661-BA588D3B-962E-4C1D-A386-32F877F58455Q34864675-549FF8B0-B4B7-4B03-BB33-CA7024423D32Q35111139-AF46FB57-9112-4572-8CDF-D9C51A8A69C1Q35768114-2C6E3A7C-8A15-4155-809B-9C89F9A1933CQ35954283-144199B3-4113-4ECA-BE24-8912AA44908CQ36010083-B25D6ACC-B626-47F5-9AFF-403662F2C9ADQ37378850-2E5EEBDA-5487-4CEF-BE91-6E451442474DQ37547261-6ECF8E45-E6A9-419D-8480-79BD2B23087FQ38153910-7F47A3C6-68EC-499F-A694-0D5DF6186A5EQ38171825-FEC56AAC-7CB1-425B-8D66-ADF611ABAC34Q38519881-B59C12A9-41AB-4031-883D-95868FE48A14Q38546746-45D1BB50-70DA-453F-A593-BC54BD9B5F50Q38628767-0FD2EC5A-1228-4652-8AE2-C08B1376DBACQ38675925-BDACD424-AEDE-495A-9FF0-13B57B61F0E6Q38728199-2FC8ED31-AE26-4577-B653-4ED57DE13190Q40123101-736D7B35-9B3C-4F1D-AC6A-93FFCAE18EBAQ40640818-1E50BBB0-DDC6-4E9D-9E6E-2426F17F0AEAQ43887271-F09C3472-0DE6-4FC1-B612-68404436BE6EQ45324172-992E9BCD-164D-4CA2-9DF5-7AE33B321A65Q55497501-90ACAD10-A66A-4813-AE53-03FF69113A74Q57008156-968C2760-6903-4BBD-8113-4D5B9F332B15
P2860
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@ast
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@en
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@en-gb
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@nl
type
label
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@ast
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@en
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@en-gb
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@nl
altLabel
A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion
@en
prefLabel
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@ast
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@en
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@en-gb
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@nl
P2093
P2860
P50
P3181
P1433
P1476
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion
@en
P2093
Alexander N Freiberg
David Meriwether
Dong Zhang
Frederic Vigant
Gleyder Roman-Sosa
Guanghou Shui
Hector C Aguilar
Hubert Buczkowski
Jennifer K Smith
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1003297
P407
P577
2013-01-01T00:00:00Z